Role of serotonin in the apomorphine-induced increase of adrenomedullary ornithine decarboxylase activity.
D015115:5,6-Dihydroxytryptamine / Q000494:pharmacology; D000313:Adrenal Medulla / Q000201:enzymology*; D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D001931:Brain Mapping; D001933:Brain Stem / Q000502:physiology*; D002262:Carboxy-Lyases / Q000378:metabolism*; D004298:Dopamine / Q000502:physiology; D010134:Fenclonine / Q000494:pharmacology; D006892:Hydroxydopamines / Q000494:pharmacology; D008297:Male; D009955:Ornithine Decarboxylase / Q000378:metabolism*; D016627:Oxidopamine; D011903:Raphe Nuclei / Q000502:physiology*; D051381:Rats; D012701:Serotonin / Q000502:physiology*
D006892:Hydroxydopamines; D012701:Serotonin; D016627:Oxidopamine; D002262:Carboxy-Lyases; D009955:Ornithine Decarboxylase; D001058:Apomorphine; D010134:Fenclonine; D004298:Dopamine; D015115:5,6-Dihydroxytryptamine